277 related articles for article (PubMed ID: 19369447)
21. Translating in vitro ligand bias into in vivo efficacy.
Luttrell LM; Maudsley S; Gesty-Palmer D
Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides.
Pioszak AA; Parker NR; Gardella TJ; Xu HE
J Biol Chem; 2009 Oct; 284(41):28382-28391. PubMed ID: 19674967
[TBL] [Abstract][Full Text] [Related]
23. Conditionally immortalized murine osteoblasts lacking the type 1 PTH/PTHrP receptor.
Divieti P; Lanske B; Kronenberg HM; Bringhurst FR
J Bone Miner Res; 1998 Dec; 13(12):1835-45. PubMed ID: 9844101
[TBL] [Abstract][Full Text] [Related]
24. Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice.
Daley EJ; Yoon SH; Reyes M; Bruce M; Brooks DJ; Bouxsein M; Potts JT; Kronenberg HM; Wein MN; Lanske B; Jüppner H; Gardella TJ
Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35460406
[TBL] [Abstract][Full Text] [Related]
25. Primary cilia and PTH1R interplay in the regulation of osteogenic actions.
Ardura JA; Martín-Guerrero E; Heredero-Jiménez S; Gortazar AR
Vitam Horm; 2022; 120():345-370. PubMed ID: 35953116
[TBL] [Abstract][Full Text] [Related]
26. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation.
Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL
J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311
[TBL] [Abstract][Full Text] [Related]
27. Roles of parathyroid hormone (PTH) receptor and reactive oxygen species in hyperlipidemia-induced PTH resistance in preosteoblasts.
Li X; Garcia J; Lu J; Iriana S; Kalajzic I; Rowe D; Demer LL; Tintut Y
J Cell Biochem; 2014 Jan; 115(1):179-88. PubMed ID: 24038594
[TBL] [Abstract][Full Text] [Related]
28. Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation.
Datta NS; Kolailat R; Fite A; Pettway G; Abou-Samra AB
Cell Signal; 2010 Mar; 22(3):457-66. PubMed ID: 19892016
[TBL] [Abstract][Full Text] [Related]
29. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
Yang Y; Wang B
Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
[TBL] [Abstract][Full Text] [Related]
30. Altered Signaling and Desensitization Responses in PTH1R Mutants Associated with Eiken Syndrome.
Portales-Castillo I; Dean T; Cheloha RW; Creemer BA; Vilardaga JP; Savransky S; Khatri A; Jüppner H; Gardella TJ
Commun Biol; 2023 Jun; 6(1):599. PubMed ID: 37268817
[TBL] [Abstract][Full Text] [Related]
31. Molecular Mechanism of Ca
Li M; Li M; Guo J
J Chem Inf Model; 2022 Nov; 62(21):5110-5119. PubMed ID: 34464108
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.
Dean T; Linglart A; Mahon MJ; Bastepe M; Jüppner H; Potts JT; Gardella TJ
Mol Endocrinol; 2006 Apr; 20(4):931-43. PubMed ID: 16339275
[TBL] [Abstract][Full Text] [Related]
33. Parathyroid hormone 1 receptor signaling mediates breast cancer metastasis to bone in mice.
Swami S; Zhu H; Nisco A; Kimura T; Kim MJ; Nair V; Wu JY
JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36692956
[TBL] [Abstract][Full Text] [Related]
34. NHERF1 regulates parathyroid hormone receptor membrane retention without affecting recycling.
Wang B; Bisello A; Yang Y; Romero GG; Friedman PA
J Biol Chem; 2007 Dec; 282(50):36214-22. PubMed ID: 17884816
[TBL] [Abstract][Full Text] [Related]
35. Eliminating phosphorylation sites of the parathyroid hormone receptor type 1 differentially affects stimulation of phospholipase C and receptor internalization.
Miedlich SU; Abou-Samra AB
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E665-71. PubMed ID: 18577695
[TBL] [Abstract][Full Text] [Related]
36. Proteolytic Cleavage of the Extracellular Domain Affects Signaling of Parathyroid Hormone 1 Receptor.
Klenk C; Hommers L; Lohse MJ
Front Endocrinol (Lausanne); 2022; 13():839351. PubMed ID: 35273573
[TBL] [Abstract][Full Text] [Related]
37. Transmembrane residues together with the amino terminus limit the response of the parathyroid hormone (PTH) 2 receptor to PTH-related peptide.
Turner PR; Mefford S; Bambino T; Nissenson RA
J Biol Chem; 1998 Feb; 273(7):3830-7. PubMed ID: 9461563
[TBL] [Abstract][Full Text] [Related]
38. Biased agonism at the parathyroid hormone receptor: a demonstration of functional selectivity in bone metabolism.
Bohinc BN; Gesty-Palmer D
Mini Rev Med Chem; 2012 Aug; 12(9):856-65. PubMed ID: 22681253
[TBL] [Abstract][Full Text] [Related]
39. RANKL/OPG system regulation by endogenous PTH and PTH1R/ATF4 axis in bone: Implications for bone accrual and strength in growing rats with mild uremia.
Znorko B; Pawlak D; Oksztulska-Kolanek E; Domaniewski T; Pryczynicz A; Roszczenko A; Rogalska J; Lipowicz P; Doroszko M; Brzoska MM; Pawlak K
Cytokine; 2018 Jun; 106():19-28. PubMed ID: 29529595
[TBL] [Abstract][Full Text] [Related]
40. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
